Congenital vascular malformation
Conditions
Interventions
treatment group:Singulair 10mg/d
Congenital vascular malformation group:whole exome sequencing
Sponsors
The Fifth Affiliated Hospital of Sun Yat-Sen University
Eligibility
Sex/Gender
All
Age
No minimum to 100 Years
Inclusion criteria
Inclusion criteria: After the patients signed the informed consent, enhanced CT and color doppler examination or DSA were performed to confirm that patients with vascular diseases could participate in this project,including hepatic hemangioma, malformation of body surface blood vessels, congenital arteriovenous malformations, visceral vascular malformations, lymphatic vessel hypoplasia, and Budd-Chiari syndrome
Exclusion criteria
Exclusion criteria: The history of surgical, infection or trauma is excluded through clinical inquiry. The possibility of infection is excluded through laboratory examination. Imaging examination is used to diagnose vascular disease and rule out the possibility of tumor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| whole exome sequencing;the effusion and absorption of lymphatic ;the changes of deformed blood and lymphatic vessels.;Changes of pleural and abdominal effusion; | — |
Countries
China
Contacts
Public ContactPengfei Pang
The Fifth Affiliated Hospital of Sun Yat-Sen University
Outcome results
None listed